Skip to: Content
Skip to: Site Navigation
Skip to: Search

July 25, 2008 7:56:22 AM CDT

Learn about Newser Points »

Stories related to: pharmaceutical industry

Stories

12 Stories

  • July 2008

    • America: Land of Doggy Doping

      newser  |  New York Times  |  Jul 10, 08 7:07 AM CDT

      America: Land of Doggy Doping

      Americans spent $49 billion on their pets last year, with an ever-growing percentage paying for treatment of  behavioral issues with tailor-made psychotropics, reports James Vlahos in the New York Times Magazine . Frustrated owners are feeding dogs drugs like Reconcile—beef-flavored Prozac—-for "mental illnesses that eerily resemble human ones," from separation anxiety to compusive disorder. There are even doggy diet pills. More »

      Tags

      pets  • New York Times  • pharmaceutical companies  • pharmaceutical industry  • veterinarian  • Prozac  • medicating pets

  • June 2008

    • Big Pharma Sickens Universities

      newser  |  Chronicle of Higher Education  |  Jun 22, 08 6:07 PM CDT

      Big Pharma Sickens Universities

      Weak legislation allows professors to collect huge under-the-table payments from Big Pharma, and it’s time to fight back, Dan Greenberg writes in the Chronicle of Higher Education . Pharmaceutical companies pay professors to shill drugs and lend their names to industry research, and the only oversight is an honor-system mechanism requiring profs to report outside income to the university—not to a federal agency. More »

      Tags

      ethics  • pharmaceutical companies  • university  • pharmaceutical industry  • academia  • pharma  • academic research

    • Deal Delays Generic Lipitor Until 2011

      newser  |  New York Times  |  Jun 18, 08 5:11 PM CDT

      Deal Delays Generic Lipitor Until 2011

      Pfizer has struck a deal with an Indian generic drug maker to delay a cheaper version of Lipitor in the US until November 2011. The agreement limiting generic versions of the cholesterol-lowering drug will translate into billions more in profits for Pfizer, the New York Times reports. Lipitor, the world's best-selling medicine, costs about $3 a day; a generic version will likely be less than $1. More »

      Tags

      pharmaceutical companies  • Pfizer  • pharmaceutical industry  • cholesterol lowering drug  • Lipitor

  • May 2008

    • Court Tosses $32M Verdict Against Vioxx

      newser  |  Wall Street Journal  |  May 14, 08 1:29 PM CDT

      Court Tosses $32M Verdict Against Vioxx

      A Texas appellate court threw out a $32 million verdict against Merck today, citing a lack of evidence that Vioxx contributed to a man’s fatal heart attack. Lionel Garza was taking the painkiller when he died in 2001 at age 71, but was also a smoker with high blood pressure and high cholesterol, the Wall Street Journal reports. The Garza case was decided by verdict in 2006, and was excluded from a recent $4.85 billion settlement for 27,000 Vioxx cases. More »

      Tags

      lawsuit  • painkiller  • pharmaceutical industry  • Vioxx  • Merck and Co.

  • March 2008

    • FDA Finds Contaminant in Blood Thinner

      newser  |  New York Times  |  Mar 5, 08 9:49 PM CST

      FDA Finds Contaminant in Blood Thinner

      The FDA has found a contaminant in samples of heparin, a blood thinner produced mainly in China linked to 19 deaths and nearly 800 allergic reactions in the US, the New York Times reports. The contaminant may be a counterfeit form of heparin added to reduce its manufacturing cost. The FDA is fine-tuning tests to better detect it. More »

      Tags

      China  • FDA  • pharmaceutical industry  • Heparin  • Baxter International  • blood thinner  • drug manufacturer

  • February 2008
  • December 2007

    • Merck Recalls 1M Doses of Vaccine for Kids

      newser  |  Associated Press  |  Dec 12, 07 7:14 PM CST

      Merck Recalls 1M Doses of Vaccine for Kids

      Merck is recalling almost a million doses of a childhood vaccine after it found evidence of contamination at one of its factories, the AP reports. The pharmaceutical giant says no children have been harmed after taking Hib, which prevents meningitis and pneumonia, but the company is recalling its 10 lots and two lots of a combination vaccine for both Hib and hepatitis B. More »

      Tags

      Merck  • vaccine  • pharmaceutical industry  • Vioxx  • pneumonia  • meningitis  • hepatitis B

    • Big Pharma Faces Big Plunge

      newser  |  Wall Street Journal  |  Dec 6, 07 4:50 AM CST

      Big Pharma Faces Big Plunge

      Patent protections on some of the pharmaceutical industry's best-selling drugs, like Lipitor, Plavix and Singulair, are due to expire in the next several years, and drug manufacturers have little in the pipeline to replace them. The drug companies will lose billions—as much as half their combined revenue—to generic competitors, triggering an unprecedented industry crisis, reports the Wall Street Journal . More »

      Tags

      GlaxoSmithKline  • Pfizer  • pharmaceutical industry  • Eli Lilly  • Lipitor  • drug manufacturer  • Zocor  • Merck and Co.  • Zyprexa  • Fosamax  • Singulair  • Plavix

  • October 2007

    • Court Blocks New Patent Rules

      newser  |  Wall Street Journal  |  Oct 31, 07 10:40 PM CDT

      Court Blocks New Patent Rules

      A Federal judge has blocked the US Patent and Trademark Office from implementing tough new patent rules with a temporary injunction in a suit brought by GlaxoSmithKline. The Wall Street Journal reports the new rules would have limited the number of times patent holders may make minor changes to existing patent applications, known as continuances, a favorite maneuver of pharma companies. More »

      Tags

      technology  • GlaxoSmithKline  • intellectual property  • pharmaceutical industry  • Patent and Trademark Office

12 Stories

Today's Most Popular

Loading...

What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »